Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer

Massachusetts General Hospital, Boston, MA 02114, USA.
New England Journal of Medicine (Impact Factor: 55.87). 08/2010; 363(8):733-42. DOI: 10.1056/NEJMoa1000678
Source: PubMed


Patients with metastatic non-small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the effect of introducing palliative care early after diagnosis on patient-reported outcomes and end-of-life care among ambulatory patients with newly diagnosed disease.
We randomly assigned patients with newly diagnosed metastatic non-small-cell lung cancer to receive either early palliative care integrated with standard oncologic care or standard oncologic care alone. Quality of life and mood were assessed at baseline and at 12 weeks with the use of the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale and the Hospital Anxiety and Depression Scale, respectively. The primary outcome was the change in the quality of life at 12 weeks. Data on end-of-life care were collected from electronic medical records.
Of the 151 patients who underwent randomization, 27 died by 12 weeks and 107 (86% of the remaining patients) completed assessments. Patients assigned to early palliative care had a better quality of life than did patients assigned to standard care (mean score on the FACT-L scale [in which scores range from 0 to 136, with higher scores indicating better quality of life], 98.0 vs. 91.5; P=0.03). In addition, fewer patients in the palliative care group than in the standard care group had depressive symptoms (16% vs. 38%, P=0.01). Despite the fact that fewer patients in the early palliative care group than in the standard care group received aggressive end-of-life care (33% vs. 54%, P=0.05), median survival was longer among patients receiving early palliative care (11.6 months vs. 8.9 months, P=0.02).
Among patients with metastatic non-small-cell lung cancer, early palliative care led to significant improvements in both quality of life and mood. As compared with patients receiving standard care, patients receiving early palliative care had less aggressive care at the end of life but longer survival. (Funded by an American Society of Clinical Oncology Career Development Award and philanthropic gifts; number, NCT01038271.)

Download full-text


Available from: Vicki A Jackson
  • Source
    • "However, 23% of these received treatment during the last month of life (N€ app€ a et al., 2011). There is increasing discussion within the field regarding whether PCT given in such a late phase has any positive effects, or might influence the patient negatively, in some cases even risking shortening their life (Asola et al., 2006; Janssens et al., 2013; Mort et al., 2008; N€ app€ a et al., 2011; Temel et al., 2010). Several recent studies show that physicians are Abbreviations: ACT, Anatomical Therapeutic Chemical classification system; ECOG PSR, European Cooperative Oncology Group Performance Status Rating; EORTOC QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30; EORTOC QLQ-C15-PAL, "
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: Palliative chemotherapy treatment (PCT) offered late in the cancer disease trajectory may be problematic. It is not easy to accurately calculate whether the potential benefits will outweigh the side-effects. This study investigates whether routine use of the Performance Status in Palliative Chemotherapy questionnaire (PSPC) affects the proportions of patients receiving PCT during the last month of life, care utilization, and documentation routines. A secondary aim was to gather registered nurses' experiences of the PSPC in routine use. Methods: Eighty incurable patients with cancer who had used the PSPC before PCT were compared to 160 matched controls, using non-parametric tests. Nurses' reflections on the PSPC were collected and reviewed. Results: No significant differences were found between users and non-users of the PSPC in terms of proportions receiving PCT during the last month of life. Higher proportions of patients older than 74 years received PCT than in previous studies (40% versus 17%). Nurses considered the questionnaires to be a valuable complement to verbal information when trying to acquire an accurate picture of patients' performance status. Conclusion: At this point in the development of the PSPC we did not find any significant decreases in the proportion of patients receiving PCT during the last month in life. However, as the nurses valued the PSPC, it can be used as a complementary tool in assessment of performance status until further research is conducted.
    Full-text · Article · Nov 2015 · European journal of oncology nursing: the official journal of European Oncology Nursing Society
    • "However, evidence-informed best practice guidelines recommend that ACP and Goals of Care (GOC) discussions be initiated earlier to direct person-centred care throughout the continuum789. Moreover, research suggests that EOL outcomes for cancer patients can be improved with early and outpatient involvement of palliative care[10]. GOC discussions are a part of ACP. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite evidence that Goals of Care (GOC) discussions should occur early in the disease trajectory, the majority occur close to end of life. In a pilot, oncologists routinely initiated GOC discussions with all patients in their everyday ambulatory practice. Following the pilot, 9 of 12 eligible oncologists participated in semi-structured interviews about their experiences. Analysis resulted in the identification of seven principles of good GOC discussions embedded in the oncologists' interviews, four barriers to engaging in GOC discussions and foundational education needs. Participants believed that the appropriate trigger for a GOC discussion is a diagnosis of advanced cancer, not simply a diagnosis of cancer, and supported the importance of selective and strategic targeting of GOC discussions. The findings have informed the development of an education-based model for culture change within a province-wide cancer care system.
    No preview · Article · Sep 2015 · Journal of Cancer Education
    • "Advances in the management of late-stage cancer are accompanied by a host of challenges for individuals, families, and society (Aronowitz, 2010). In particular , the use of aggressive cancer-directed therapies in persons with very advanced disease is associated with psychosocial, physical, and existential distress and poorer quality-of-life (Schroepfer, 2007; Temel et al., 2010; Tullis, 2010; Wright et al., 2008). Geriatric cancer patients are particularly susceptible to the toxic side-effects of chemotherapy (Balducci, 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Disease-directed therapy near death is a growing trend among persons living with late-stage cancer. As a sociocultural phenomenon, cancer-directed therapy (e.g., chemotherapy) when given for very advanced disease is a process that offers questionable benefits and portends further suffering, but also suggests potential for growth and transcendence. Theories and concepts drawn from cultural anthropology, sociology, and existentialism illustrate how contextual factors contribute to the creation of a “liminal space”; the latter part of the cancer trajectory where living and dying can overlap. When applied to clinical practice, this theoretical framework gives the patient, family, and health care provider a way of “unmasking” a period of transition during terminal illness when aggressive disease-directed care continues to be provided. The liminal space may function as an existential plane; a gateway or threshold with inherent potential for psychospiritual development during the final stage of life.
    No preview · Article · Jun 2015 · OMEGA--Journal of Death and Dying
Show more